DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Abraxane (Paclitaxel) - Current Clinical Trials

 
 



Abraxane Related Clinical Trials

Hepatic Arterial Infusion (HAI) of Abraxane [Active, not recruiting]

Phase I & II Trial of Intravesicular Abraxane for Treatment-refractory Bladder Cancer [Recruiting]

Phase I/II Trial of the Combination of Lenalidomide (Revlimid) and Nab-paclitaxel (Abraxane) in the Treatment of Relapsed/Refractory Multiple Myeloma [Recruiting]

Gemcitabine, Cisplatin, and Abraxane in Advanced Biliary Cancers [Recruiting]

Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer [Recruiting]

HAI Abraxane With Gemcitabine and Bevacizumab [Completed]

Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma [Active, not recruiting]

Safety and Efficacy Study of Abraxane Plus Gemcitabine in Chinese Patients With Metastatic Pancreatic Cancer [Active, not recruiting]

Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer [Active, not recruiting]

Abraxane in CIMP-High Colorectal and Small Bowel Adenocarcinomas [Active, not recruiting]

A Phase I Trial of Abraxane, Cisplatin and 5-Fluorouracil Along With Chemoradiotherapy in Advanced Head and Neck Cancer [Active, not recruiting]

Phase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic Melanoma [Recruiting]

A Study of Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane« as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic Cancer [Recruiting]

Bevacizumab and Abraxane as Second-line Therapy in Triple Negative Metastatic Breast Cancer [Completed]

A Combination of Abraxane and Cisplatin in Metastatic Breast Cancer [Completed]

Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers [Completed]

Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic Melanoma [Completed]

Dose Dense Abraxane in Adjuvant Chemotherapy for Breast Cancer [Completed]

Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer [Completed]

Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer [Terminated]

Study Of Abraxane´┐Ż And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast Cancer [Terminated]

Safety and Efficacy Study of Nab«-Paclitaxel With CC-486 and Nab«-Paclitaxel Monotherapy as Second Line Treatment for Advanced Nonsquamous Non-small Cell Lung Cancer [Recruiting]

Efficacy & Safety of ODSH (2-0, 3-0 Desulfated Heparin) in Patients With Metastatic Pancreatic Cancer Treated With Gemcitabine & Abraxane [Recruiting]

Study of Abraxane and Carboplatin to Treat Small Cell Lung Cancer [Active, not recruiting]

Phase I/II Study of Abraxane in Recurrent and Refractory Lymphoma [Active, not recruiting]

Phase 2 Nab« -Paclitaxel (Abraxane«) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC) [Recruiting]

Hepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanoma in the Liver [Completed]

Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck [Active, not recruiting]

Open-label Phase 1b Study of ARQ 092 in Combination With Carboplatin Plus Paclitaxel [Recruiting]

Neoadjuvant Trial of Nab-Paclitaxel and MPDL3280A [Not yet recruiting]

A Phase I Trial of the Combination of AZD2014 and Weekly Paclitaxel. [Recruiting]

BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors [Recruiting]

Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer [Terminated]

Schedules of Nab-Paclitaxel in Metastatic Breast Cancer [Active, not recruiting]

Phase II Trial Comparing ABI-007 (Abraxane«, Nab«-Paclitaxel) to Taxotere in First Line Therapy of Patients With Stage IV Breast Cancer [Completed]

Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic Cancer [Completed]

Efficacy and Safety With Albumin-bound Paclitaxel (Abraxane) in the TAC as Neoadjuvant Chemotherapy in Breast Cancer [Recruiting]

Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma [Completed]

Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer [Active, not recruiting]

A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers [Terminated]

Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer [Recruiting]

Study of Gemcitabine and Abraxane for Pancreas Cancer [Recruiting]

Abraxane and Alimta in Advanced Solid Tumors [Completed]

Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer [Completed]

Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer [Completed]

Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer [Active, not recruiting]

A Randomized Study of Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer [Withdrawn]

A Phase II Study Of Abraxane and Nexavar in the First-Line Treatment of Locally Advanced or Metastatic Breast Cancer [Terminated]

Weekly Nanoparticle Albumin-Bound Paclitaxel (Abraxane) + Weekly Cetuximab + Radiation Therapy (IMRT, Intensity-Modulated Radiation Therapy) in Patients With Stage III-IVB Head and Neck Squamous Cell Carcinoma (HNSCC) [Active, not recruiting]

Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients With Metastatic Gastroesophageal Cancer [Recruiting]

A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma [Completed]

Study of Gemcitabine and Abraxane to Treat Potentially Operable Pancreatic Cancer [Completed]

Study of Concurrent Paclitaxel and Radiation: Correlation of Tumor Profiles With Pathologic Response [Recruiting]

PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Subjects With Stage IV Untreated Pancreatic Cancer [Recruiting]

Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer [Recruiting]

Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic Adenocarcinoma [Completed]

Phase II Neoadjuvant Chemotheraphy (Gemcitabine and Nab-Paclitaxel vs. mFOLFIRINOX) and Sterotatic Body Radiation Therapy for Borderline Resectable Pancreatic Cancer [Recruiting]

Study Comparing Nanoparticle-based Paclitaxel With Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Patients With Early Breast Cancer (GeparSepto) [Active, not recruiting]

Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer [Terminated]

Trial of Paclitaxel/Bevacizumab +/- Everolimus for Patients With HER2-Negative Metastatic Breast Cancer [Completed]

Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treatment of Advanced Urothelial Cancer [Completed]

The Addition of Nab-paclitaxel (Abraxane) to First Line Treatment of Metastasized Oesophagogastric Carcinoma (ACTION) [Recruiting]

Neoadjuvant Chemotherapy With Nab-paclitaxel in Women With HER2-negative High-risk Breast Cancer [Active, not recruiting]

Phase 1b/2 Study of U3-1287 in Combination With Trastuzumab Plus Paclitaxel in Newly Diagnosed Metastatic Breast Cancer (MBC) [Active, not recruiting]

PH I SRC Kinase, Dasatinib Combo Paclitaxel & Carboplatin in Pts w Ovarian, Peritoneal, & Tubal Cancer [Completed]

Breast Cancer Treatment Using Weekly Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting [Recruiting]

Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer [Recruiting]

Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) [Completed]

ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer [Completed]

A Phase I/II Study of ABI-007 (Abraxane«, Nab«-Paclitaxel)and Vinorelbine in Patients With Stage IV (Metastatic) Breast Cancer [Terminated]

Treatment With Nab-paclitaxel in Cutaneous SCC [Not yet recruiting]

Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Metastatic Pancreatic Cancer [Not yet recruiting]

To Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors [Recruiting]

Study of Vemurafenib, Carboplatin, and Paclitaxel [Recruiting]

Pharmacokinetic and Safety Study of Nab«-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia [Recruiting]

Dose Escalation and Pharmacokinetic Study of Paclitaxel Liposome Injection in Treating Patients With Advanced Solid Tumor After Failure From Conventional Treatments [Recruiting]

Neoadjuvant TDM1 With Lapatinib and Abraxane Compared With Trastuzumab With Lapatinib and Paclitaxel [Recruiting]

Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194 [Active, not recruiting]

Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Nab-paclitaxel (Abraxane) in Pancreatic Cancer [Not yet recruiting]

Efficacy of ABI-007 Plus Gemcitabine or sLV5FU2 as First-line Therapy in Patients With Metastatic Pancreatic Cancer [Active, not recruiting]

Nab-paclitaxel in Combination With Gemcitabine in Fragile Patients With Advanced Pancreatic Cancer [Recruiting]

A Study of Ramucirumab (IMC-1121B) and Paclitaxel in Participants With Solid Tumors [Active, not recruiting]

Therapy With Abraxane and 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) for Patients With Breast Cancer [Completed]

HSP90 Inhibitor AT13387 and Paclitaxel in Treating Patients With Advanced Triple Negative Breast Cancer [Not yet recruiting]

Phase 2 Study With Abraxane (Nab«Paclitaxel) in Metastatic Colorectal Cancer [Active, not recruiting]

S-1 in Combination With Abraxane in Treating Cholangiocarcinoma [Recruiting]

Bioequivalence Study of IG-001 Versus Nab-paclitaxel in Metastatic or Locally Recurrent Breast Cancer [Active, not recruiting]

Study to Determine Efficacy and Safety of CC-486 With Nab-Paclitaxel Versus Nab-Paclitaxel in Patients With Chemotherapy naïve Metastatic Melanoma [Withdrawn]

Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma [Recruiting]

Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast Ca [Active, not recruiting]

Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Completed]

Investigating Safety, Tolerability and Efficacy of AZD5363 When Combined With Paclitaxel in Breast Cancer Patients [Recruiting]

Single Arm on the Tolerability of Weekly Nab-paclitaxel [Recruiting]

Paclitaxel-Carboplatin-Bevacizumab +/- Nitroglycerin in Metastatic Non-Squamous-Non-Small Cell Lung Cancer [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015